ArticleFrontiers in cardiovascular medicine2022

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease.

Aditya Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.